Patients with rheumatic heart disease who took the heart failure drug digoxin were 18% less likely to die or experience ...
Senior researcher Dr Ali Ahmed (University of Alabama, Birmingham) told heartwire that the differing conclusions are the result of two different methodologies used to analyze the data. He said their ...
A proof-of-concept trial by researchers at ETH Zurich, the University Hospitals of Basel and Zurich, and the Basel-Land Cantonal Hospital, demonstrated that treating breast cancer patients with a low, ...
Findings from the current study demonstrate that over half of chronic HF patients in the DIG trial had severe and more advanced disease as evidenced by the presence of NYHA III–IV symptoms, LVEF <25%, ...
People prescribed digoxin are being urged by the NHS to speak to their doctor if they experience two common side effects. Digoxin is a cardiac gylocoside medicine that is regulary prescribed to reat a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results